Mylan
ARIXTRA
Manufacturer:
Mylan
Name:
ARIXTRA
HCPCS Code Descriptor:
Injection, fondaparinux sodium, 0.5 mg
Category:
J Code
HCPCS:
J1652
NDC(s):
70710-1515-06, 70710-1514-06, 70710-1514-09, 67457-0595-08, 67457-0594-06, 67457-0593-04, 67457-0592-10, 67457-0584-06, 67457-0585-08, 67457-0582-10, 67457-0583-04, 55150-0233-10, 55150-0232-10, 55150-0230-10, 55150-0231-10, 55111-0681-10, 55111-0681-02, 55111-0680-02, 55111-0680-10, 55111-0679-10, 55111-0679-02, 55111-0678-10, 55111-0678-02, 43598-0606-02, 43598-0606-10, 43598-0609-10, 43598-0609-02, 43598-0608-10, 43598-0608-02, 43598-0607-10, 43598-0607-02, 00781-3476-95, 00781-3465-95, 00781-3476-12, 00781-3454-12, 00781-3454-95, 00781-3465-12, 00781-3443-95, 00781-3443-12
Primary Type:
Anti-coagulant
Generic Status:
Multi-Source
Route of Administration:
Subcutaneous
About:
ARIXTRA is an Anti-coagulant drug manufactured by Mylan and administered via the Subcutaneous route of administration. The J Code: J1652 is aligned to the drug ARIXTRA.